molecular detection of prostate specific antigen in patients with prostate cancer or benign prostate hyperplasia the first investigation from iran

Authors

l andonian

mr khorramizadeh

dd farhud

m hashemzadeh chaleshtori

abstract

prostate cancer is the second common form of cancer in men. detection of circulating prostate specific antigen (psa) transcripts has effectively been used for early diagnosis of prostate cancer cells. this investigation employed a reverse transcriptase polymerase chain reaction (rt-pcr) technique to distinguish the patients with either localized or metastatic prostate cancer (cap) vs. benign prostate hyperplasia (bph) and control subjects, as compared with clinical and pathological records. with reservation of ethical issues, blood samples were collected from 60 cases. based on pathological and clinical findings, 25 patients (20 with localized cancer, 5 with metastatic), 22 with bph, and 13 healthy (including 3 females) subjects as negative controls, were selected from shariati, mehrad, sina,, khatam and atie hospitals in tehran, iran. rt-pcr for a 260 bp psa transcript was then performed. clinical and pathological records were used for the assessment and comparison of psa rt-pcr results. none of the control subjects and bph (with 7 exceptions) were found positive by rt-pcr (relative specificity= 72.7%). in patients with prostate cancer, 21 out of 25 were found psa positive (relative sensitivity=83.4%) and the remaining 3 have been shown to be psa negative (positive predictive value= 83.4%). all of 5 metastatic patients (100%) revealed psa positive results. our data reflects the clinical relevance and significance of rt-pcr results as assessed with clinical and pathological examinations. psa rt-pcr might be used as a powerful means for diagnosis, even when either pathological or clinical findings are negative, and could be employed for further molecular epidemiology surveys.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Molecular Detection of Prostate Specific Antigen in Patients with Prostate Cancer or Benign Prostate Hyperplasia the First Investigation from Iran

Prostate cancer is the second common form of cancer in men. Detection of circulating Prostate Specific Antigen (PSA) transcripts has effectively been used for early diagnosis of prostate cancer cells. This investigation employed a reverse transcriptase polymerase chain reaction (RT-PCR) technique to distinguish the patients with either localized or metastatic prostate cancer (CaP) vs. Benign Pr...

full text

Evaluation of Plasma Interleukin-8 Concentration in Patients with Prostate Cancer and Benign Prostate Hyperplasia

Background: Prostate specific antigen (PSA) has been used as a screening test for the early detection of prostate cancer (PC) for many years. Although the introduction of PSA test led to a considerable increase in reported prostate cancer cases, there is still some controversy over the sensitivity and specificity of this marker in distinguishing PC patients from those with benign prostate hyper...

full text

Prostate-specific membrane antigen levels in sera from healthy men and patients with benign prostate hyperplasia or prostate cancer.

Prostate-specific membrane antigen (PSMA) serum levels have been proposed to be of prognostic significance in patients with advanced prostate disease. The objective of the present study was to confirm PSMA serum expression by Western blot techniques, to determine whether such data could assist in the differentiation of benign from malignant prostatic disease, and to determine the suitability of...

full text

Study of Correlation between Prostate Specific Antigen and Matrix Metalloproteinase-2 Activity in Benign and Malignant Prostate Hyperplasia

There are emerging data on novel tumor markers such as matrix metalloproteinase-2 (MMP-2 or gelatinase-A), which play a key role in tissue invasion and metastasis. We designed an investigation to assess the usefulness of MMP-2 activity as compared to prostate specific antigen (PSA) in cancer staging process. We have analyzed the circulating form of MMP-2 in serum samples of patients suffering f...

full text

Age Specific Reference Levels of Serum Prostate-Specific Antigen, Prostate Volume and Prostate Specific Antigen Density in Healthy Iranian Men

Background: It is relevant to highlight that there is not a precise and perfect report on either 95 percentile value (upper limit of normal range) or on appropriate reference intervals for serum PSA in Iranian population. Objective: To determine age-specific reference ranges for serum prostate-specific antigen (PSA) concentration and PSA density (PSAD) and prostate volumes in a population of he...

full text

What is the most appropriate test in detecting prostate cancer in patients with intermediate prostate specific antigen levels?

  Abstract   Background: Regarding the variety of tests present for detecting and also screening   prostate cancer and also bearing in mind the advantages and disadvantages of   these tests we decided to re-evaluate these tests (total prostate specific antigen and all   of its modifications) in detecting prostate cancer in men with intermediate serum   PSAlevels.   Methods: Following a cross se...

full text

My Resources

Save resource for easier access later


Journal title:
iranian journal of public health

جلد ۳۴، شماره ۳، صفحات ۲۰-۲۶

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023